Home › Funds › Velan Capital Investment Management LP › STRO
Velan Capital Investment Management LP position in STRO
SUTRO BIOPHARMA INC · Health Care
Velan Capital Investment Management LP reported holding 510,038 shares of STRO (SUTRO BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 7.84% of its reported portfolio and ranking #4 among its reported holdings. Velan Capital Investment Management LP has disclosed STRO holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's STRO position evolved
Velan Capital Investment Management LP first disclosed a stake in STRO in Q4 2024 at 30,000 shares (US$55K). The position peaked in Q2 2026 at 512,160 shares, worth US$17.0M. Across 8 filings, Velan Capital Investment Management LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 510,038 shares valued at US$8.2M. Notable position changes include a 3333% increase in Q1 2025 (shares rose 9% over the following quarter), a 197% increase in Q2 2025 (shares rose 23% over the following quarter), a 90% trim in Q4 2025 (shares rose 115% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 30.00K | $55.20K | New |
| Q1 2025 | 1.03M | $670.12K | Add |
| Q2 2025 | 3.06M | $2.18M | Add |
| Q3 2025 | 3.12M | $2.71M | Add |
| Q4 2025 | 312.00K | $3.61M | Reduce |
| Q1 2026 | 512.16K | $12.76M | Add |
| Q2 2026 | 512.16K | $17.00M | Hold |
| Q3 2026 | 510.04K | $8.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STRO and 13F data
STRO (SUTRO BIOPHARMA INC) is a Health Care company. 34 other funds we track also report a position in STRO — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$43.3M), BVF INC/IL (US$41.6M), Samsara BioCapital, LLC (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STRO
- PERCEPTIVE ADVISORS LLC 1.30M sh · $43.32M · Q2 2026
- BVF INC/IL 1.25M sh · $41.56M · Q2 2026
- Samsara BioCapital, LLC 1.06M sh · $35.29M · Q2 2026
- Affinity Asset Advisors, LLC 1.15M sh · $18.57M · Q3 2026
- Kynam Capital Management, LP 872.56K sh · $14.06M · Q3 2026
- Merck & Co., Inc. 272.35K sh · $4.39M · Q3 2026
- Seven Fleet Capital Management LP 159.12K sh · $3.79M · Q2 2026
- KVP Capital Advisors, LP 226.57K sh · $3.65M · Q3 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held STRO?
Velan Capital Investment Management LP has disclosed STRO holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Velan Capital Investment Management LP's current position in STRO?
As of Q3 2026, Velan Capital Investment Management LP holds 510.04K shares of STRO (SUTRO BIOPHARMA INC), valued at $8.22M, representing 7.84% of its reported portfolio and ranking #4.
Has Velan Capital Investment Management LP been buying or selling STRO?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in STRO. The position peaked in Q2 2026 at 512.16K shares.
Which other funds hold STRO?
Other major institutional holders of STRO include PERCEPTIVE ADVISORS LLC, BVF INC/IL, Samsara BioCapital, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.